CareDx (CDNA) Tops Q2 EPS by 65c ; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P on track for muted open as Middle East tensions weigh; AI stocks boost Nasdaq
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- Fulcrum Therapeutics to merge with Slate Medicines in all-stock deal
- Piper Sandler Starts SoFi Technologies (SOFI) at Overweight
CareDx, Inc (CDNA) PT Raised to $30 at Jefferies
August 1, 2024 7:01 AM EDTJefferies analyst Tycho Peterson raised the price target on CareDx, Inc (NASDAQ: CDNA) to $30.00 (from $17.00) while maintaining a Buy rating.
The analyst comments "CDNA's 2Q revenues significantly beat expectations, even when normalizing for prior period adjustments (+16% above). FY revenue guidance also marched... More
